61 SPXIQ

GILD Gilead Sciences, Inc.

Healthcare · Drug Manufacturers - General

$148.74 +5.3% upside
Mean Target
$156.59
Consensus
1.7 - Buy
Analysts
27
Rank
#83 / 499
Upside Rank
#339
Analyst Price Target Distribution
$118
Low
$160
Median
$157
Mean
$177
High
Current $149
Mean $157
Median $160
94 estimates
Consensus
1.7 - Buy
52-Wk Low
$93.37
52-Wk High
$157.29
50-Day Avg
$135.25
Recent Analyst Ratings
FirmRatingTargetPriorDate
Needham Buy $170 $170 2026-02-23
Barclays Equal-Weight $155 — 2026-02-20
RBC Capital Sector Perform $118 $103 2026-02-11
Truist Securities Buy $152 $145 2026-02-11
Wells Fargo Overweight $165 $150 2026-02-11
Healthcare Peers
ABT ABBV A ALGN AMGN BAX BDX TECH BIIB BSX BMY CAH CNC COR CRL CI COO CVS DHR DVA DXCM EW ELV GEHC